Electrical stimulation and stem cell subdural implantation decrease microglia reactivity after spinal cord injury
Mannino L., Marracino P., Roca FG., Lopez-Mocholi E., Pedraza-Boti M., Bernardi D.
Laboratory Study on Spinal Cord Injury, Neuroinflammation, Immune Modulation, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Mater Today Bio (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42317520
- PMCID
- PMC13273593
- DOI
- 10.1016/j.mtbio.2026.103329
Abstract (original English)
Background Contusive spinal cord injury (SCI) leads to severe and permanent motor, sensory, and autonomic deficits, resulting from both the initial mechanical damage and subsequent secondary pathological cascades. Besides, electrical stimulation (ES) and stem cell therapies have emerged as promising strategies to promote axonal regeneration and neuronal plasticity. Methods We designed a new implantable device, an Electro Pulsed Biohybrid (EPB) device, to provide local ES and carry stem cells (hMSC and iNSC) for subdural implantation, wired and wireless controlled. We assessed locomotion and sensory outputs, cell migration, neuroinflammation, gliosis, fibrosis, and neuronal survival. Results The consecutive application of microsecond pulsed electric fields (μsPEFs) into two different configurations during ten days and further continuous current during five days significantly enhanced the migration and engraftment of the implanted hMSC and a significant reduction in the number of microglia injury-dependent reactive cells. The ES did not exacerbate gliosis, fibrosis, neuropathic pain, or neuronal loss after primary trauma, instead, the electrically stimulated animals in comparison with the non-stimulated controls were able to perform better reducing the time during running. Consistent results were obtained with a wireless and wired configuration for the ES supply. Conclusions The
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci